Month: February 2021

New York, Feb. 03, 2021 (GLOBE NEWSWIRE) — Gurugram, India, February 4, 2021 / New York , February 3, 2021 MakeMyTrip Limited (Nasdaq: MMYT) (“MMYT” or the “Company”) today announced that it proposes to offer up to $175 million in aggregate principal amount of convertible senior notes due 2028 (the “Notes”) (the “Notes Offering”). The interest rate, the initial conversion rate and other terms of the Notes have not been finalized and will be determined at the time of pricing of the Notes Offering. The Company intends to grant to the initial purchasers in the Notes Offering a 30-day option to purchase up to an additional $25 million in aggregate principal amount of the Notes. The Notes Offering is subject to market conditions and other factors.When issued, the Notes will be senior, unsecured obligations of the Company and will mature...

CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that Pablo J. Cagnoni, M.D., president and chief executive officer, and the executive management team will participate in a fireside chat at the Guggenheim Healthcare Talks | 2021 Oncology Days on February 11, 2021, at 2:30 p.m. EST.A live audio webcast will be available within the Investors & Media section of the Rubius Therapeutics website. An archived replay will be accessible for 90 days following the event.About Rubius TherapeuticsRubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red...

New York, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) — Astrea Acquisition Corp. (NASDAQ: ASAXU) (the “Company”) announced that it priced its initial public offering of 15,000,000 units at $10.00 per unit.  The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “ASAXU” beginning tomorrow, February 4, 2021.  Each unit consists of one share of common stock and one-half of one warrant to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. Once the securities comprising the units begin separate trading, the common stock and warrants are expected to be listed on Nasdaq under the symbols “ASAX” and “ASAXW,” respectively.EarlyBirdCapital, Inc. is acting as the sole book running manager for the offering. The Company has granted the underwriters a 45-day option to purchase...

CONCORD, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Technical Communications Corporation (OTCQB: TCCO) today announced that on February 1, 2021, the Company received a loan from bankHometown under the U.S. Small Business Administration’s Paycheck Protection Program as authorized under the Economic Aid to Hard-Hit Small Businesses, Nonprofits, and Venues Act (the “Economic Aid Act”). The loan, evidenced by a promissory note, is in the principal amount of $474,400 and all or a portion of the loan is expected to be forgiven under the provisions of the Economic Aid Act. Any portion of the loan that is not eligible to be forgiven will be paid back over five years at an interest rate of 1% per year.Commenting on the good news, Carl H. Guild, Jr., President and Chief Executive Officer of TCC, said, “We again collaborated with bankHometown...

Not for distribution to U.S. newswires or for dissemination in the United StatesEquity offering will strengthen NFI’s balance sheet, reduce leverage, improve liquidity, and position the company to capitalize on operational enhancements and growth opportunitiesWINNIPEG, Manitoba, Feb. 03, 2021 (GLOBE NEWSWIRE) — (TSX:NFI) NFI Group Inc. (“NFI” or the “Company”), one of the world’s leading independent bus and coach manufacturers, today announced that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by Scotiabank, BMO Capital Markets and CIBC Capital Markets pursuant to which the Company will issue from treasury, and the Underwriters will purchase on a bought deal basis, 8,446,000 common shares (the “Shares”) at a price of C$29.60 per Share for gross proceeds to the...

CHARENTON-LE-PONT, France, and SAN RAMON, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — EssilorLuxottica and CooperCompanies, two of the world’s leading vision care companies, have entered into an agreement to create a 50/50 joint venture for the acquisition of SightGlass Vision, a U.S. based life sciences company focused on developing innovative spectacle lenses to reduce the progression of myopia in children.EssilorLuxottica and CooperCompanies will leverage their shared expertise and global leadership in myopia management to accelerate the commercialization of SightGlass Vision spectacle lenses. Through this partnership, they will further strengthen innovation opportunities and go-to-market capabilities to grow the myopia control category. SightGlass Vision’s technology will complement both companies’ existing solutions, including Essilor’s...

EssilorLuxottica and CooperCompaniesAnnounce Joint Venture for Acquisition of SightGlass VisionCharenton-le-Pont, France, and San Ramon, Calif. (February 3, 2021) – EssilorLuxottica and CooperCompanies, two of the world’s leading vision care companies, have entered into an agreement to create a 50/50 joint venture for the acquisition of SightGlass Vision, a U.S. based life sciences company focused on developing innovative spectacle lenses to reduce the progression of myopia in children.EssilorLuxottica and CooperCompanies will leverage their shared expertise and global leadership in myopia management to accelerate the commercialization of SightGlass Vision spectacle lenses. Through this partnership, they will further strengthen innovation opportunities and go-to-market capabilities to grow the myopia control category. SightGlass Vision’s...